Irinotecan Hydrochloride Liposome Injection (II); Oxaliplatin; 5Fluorouracil; Calcium folinate

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in First-line Treatment of Metastatic Pancreatic Cancer

Drug Information

Target Indication

First-line Treatment of Metastatic Pancreatic Cancer

Clinical Trial

Last updated: 10/16/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

JHPCY

Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR

Related Pipeline

Advanced Solid Tumor

Second-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based Therapy

KNEE OSTEOARTHRITIS

Neuromuscular Blockade

Neuromuscular Blockade

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts